Page last updated: 2024-09-03

clofarabine and oligonucleotides

clofarabine has been researched along with oligonucleotides in 3 studies

Compound Research Comparison

Studies (clofarabine)	Trials (clofarabine)	Recent Studies (post-2010) (clofarabine)	Studies (oligonucleotides)	Trials (oligonucleotides)	Recent Studies (post-2010) (oligonucleotides)
424	101	280	23,128	245	7,331

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Ayres, M; Bonate, P; Du, M; Faderl, S; Gandhi, V; Kantarjian, H; Keating, MJ; Plunkett, W; Rios, MB	1
Chen, M; Chen, Z; Fan, H; Liu, R; Zhang, J	1

Trials

1 trial(s) available for clofarabine and oligonucleotides

Article	Year
Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Dec-15, Volume: 9, Issue:17 Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Clofarabine; DNA; Dose-Response Relationship, Drug; Humans; Leukemia; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Models, Chemical; Neoplastic Cells, Circulating; Oligonucleotides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors	2003

Article

Year

Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Dec-15, Volume: 9, Issue:17

Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Clofarabine; DNA; Dose-Response Relationship, Drug; Humans; Leukemia; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Models, Chemical; Neoplastic Cells, Circulating; Oligonucleotides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors

2003

Other Studies

2 other study(ies) available for clofarabine and oligonucleotides

Article	Year
New drugs and dosage forms. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Feb-01, Volume: 62, Issue:3 Topics: Adenine Nucleotides; Adolescent; Adult; Aptamers, Nucleotide; Arabinonucleosides; Azabicyclo Compounds; Child; Child, Preschool; Clofarabine; Contraindications; Diethylcarbamazine; Dosage Forms; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Humans; Iloprost; Infant; Meglumine; Middle Aged; Oligonucleotides; omega-Conotoxins; Organometallic Compounds; Piperazines; Saquinavir; Trypan Blue	2005
A cocktail therapeutic strategy based on clofarabine-containing aptamer-PROTAC for enhanced cancer therapy. Chemical communications (Cambridge, England), 2023, Sep-26, Volume: 59, Issue:77 Topics: Clofarabine; Combined Modality Therapy; Endonucleases; Humans; Neoplasms; Nucleosides; Oligonucleotides	2023

Article

Year

New drugs and dosage forms.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Feb-01, Volume: 62, Issue:3

Topics: Adenine Nucleotides; Adolescent; Adult; Aptamers, Nucleotide; Arabinonucleosides; Azabicyclo Compounds; Child; Child, Preschool; Clofarabine; Contraindications; Diethylcarbamazine; Dosage Forms; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Humans; Iloprost; Infant; Meglumine; Middle Aged; Oligonucleotides; omega-Conotoxins; Organometallic Compounds; Piperazines; Saquinavir; Trypan Blue

2005

A cocktail therapeutic strategy based on clofarabine-containing aptamer-PROTAC for enhanced cancer therapy.

Chemical communications (Cambridge, England), 2023, Sep-26, Volume: 59, Issue:77

Topics: Clofarabine; Combined Modality Therapy; Endonucleases; Humans; Neoplasms; Nucleosides; Oligonucleotides

2023